Immunotherapy for Multiple Myeloma

In this segment, Keith Stewart, MB, ChB; Ivan M. Borrello, MD; Gareth Morgan, MD, PhD; Sagar Lonial, MD; Thomas G. Martin, MD; and Saad Z. Usmani, MD, consider the potential of immunotherapy in multiple myeloma, as a result of emerging data that suggest the effectiveness of using checkpoint inhibitors for the treatment of the disease.